Correspondence 0001193125-24-094628 from CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362) (CSTL)
CASTLE BIOSCIENCES INC (CSTL) (CIK 0001447362)
Date: April 12, 2024 · CIK: 0001447362 · Accession: 0001193125-24-094628
AI Filing Summary & Sentiment
File numbers found in text: 333-277470
Show Raw Text
CORRESP 1 filename1.htm CORRESP CASTLE BIOSCIENCES, INC. 505 S. Friendswood Drive, Suite 401 Friendswood, Texas 77546 April 12, 2024 Division of Corporation Finance Office of Trade & Services United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 RE: Castle Biosciences, Inc. Registration Statement on Form S-3 File No. 333-277470 Ladies and Gentlemen: Castle Biosciences, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 (File No. 333-277470) to become effective on Tuesday, April 16, 2024, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez of Cooley LLP, counsel to the Registrant, at (858) 550-6157 or, in his absence, Thomas Coll at (858) 550-6013 or Sarah Curry at (212) 479-6652. [remainder of page intentionally left blank] Very truly yours, CASTLE BIOSCIENCES, INC. By: /s/ Derek J. Maetzold Name: Derek J. Maetzold Title: President and Chief Executive Officer cc: Carlos Ramirez, Cooley LLP Thomas Coll, Cooley LLP Sarah Curry, Cooley LLP